4(top 4%)
Impact Factor
4.5(top 4%)
extended IF
19(top 18%)
H-Index
115
authors
138
papers
1K
citations
410
citing journals
1.3K
citing authors

Most Cited Articles of Hepatic Oncology

TitleYearCitations
Molecular classification of hepatocellular carcinoma: potential therapeutic implications201578
Mechanisms of doxorubicin resistance in hepatocellular carcinoma201677
Hepatocellular carcinoma treatment: hurdles, advances and prospects201838
Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress201535
Biomarker development for hepatocellular carcinoma early detection: current and future perspectives201735
JAK/STAT signaling in hepatocellular carcinoma202032
STAT3 in hepatocellular carcinoma: new perspectives201430
Dysregulated fatty acid metabolism in hepatocellular carcinoma201629
The role of the innate immune system in the development and treatment of hepatocellular carcinoma202025
RFA plus lyso-thermosensitive liposomal doxorubicin: in search of the optimal approach to cure intermediate-size hepatocellular carcinoma201625
Systemic treatments for hepatocellular carcinoma: challenges and future perspectives201824
Molecular classification of hepatocellular adenomas: impact on clinical practice201824
Locoregional therapies in cholangiocarcinoma201723
Epidemiologic, humanistic and economic burden of hepatocellular carcinoma in the USA: a systematic literature review202021
Malignant transformation of hepatocellular adenoma201419
Updates of colorectal cancer liver metastases therapy: review on DEBIRI202017
Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapies202016
Radiologic criteria of response to systemic treatments for hepatocellular carcinoma201715
The role of AEG-1 in the development of liver cancer201515
Tivantinib in MET-high hepatocellular carcinoma patients and the ongoing Phase III clinical trial201414
A perspective on molecular therapy in cholangiocarcinoma: present status and future directions201414
Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review202013
How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinoma201812
Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond?201612
Apoptosis in liver carcinogenesis and chemotherapy201512